Eric Easom - Chief Executive Officer, Director at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
ANTX on Nasdaq
All Insider Reports
All Insider Reports

Eric Easom - trading volume in the past year for AN2 Therapeutics, Inc.

Holdings reported by Eric Easom for AN2 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 256,380 $273,429 $1.07 02 Jun 2025 Direct
Common Stock 97,058 $125,204 $1.29 02 Jun 2025 Indirect
Stock Option (right to buy) 290,500 26 Feb 2025 Direct Common Stock

Transactions reported by Eric Easom for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.